Steven Altschuler is the founder of Corner Therapeutics. Corner Therapeutics has raised $54M in total funding. Latest round: Series A.
Steven M. Altschuler, M.D., is the Co-founder, Chair, and CEO of Corner Therapeutics, a biotechnology company focused on immunotherapies for cancer and infectious diseases. He previously served as a managing director of healthcare ventures at Ziff Capital Partners.
Full founder directory · Investor directory · Company funding database · Fundraising library